A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjects

NCT03215966 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

COMBINATION_PRODUCT: Macitentan / tadalafil FDC
DRUG: Macitentan (Opsumit®)
DRUG: Tadalafil (Adcirca®)

Sponsor

Actelion